glutathione kills triple negative cancer Ferroptosis heterogeneity in triple-negative breast reveals an innovative immunotherapy combination strategy Targeting the redox-programmed cell death
Targeting the redox programmed cell death axis in breast cancer: from molecular mechanisms to therapeutic resistance Cell Death Discovery Excessive glutathione intake contributes to chemotherapy resistance in breast cancer: a propensity score matching analysis World Journal of Surgical Oncology Springer Nature Link Frontiers Metabolic Reprogramming in Triple Negative Breast Cancer Glutathione responsive nanomedicine leverages tumor redox imbalance for targeted cancer theranostics Discover Oncology Springer Nature Link GSTP1 Is a Driver of Triple Negative Breast Cancer Cell Metabolism and Pathogenicity ScienceDirect
Pay in 4 interest-free payments of $6.51 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 18 - Sep 23




